We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A New Nanotechnology-Based COVID-19 Vaccine Candidate

News   Mar 03, 2021 | Original story from the Cleveland Clinic

 
A New Nanotechnology-Based COVID-19 Vaccine Candidate
 
 
Advertisement
 

RELATED ARTICLES

UK Government-Funded COVID-19 Vaccine Phase 1/2 Trials Report Positive Data

News

A new COVID-19 vaccine candidate – VLA2001 – developed by Valneva has shown positive results in a UK Government-funded Phase I/II clinical trial, according to a press release.

READ MORE

New Classification System Developed for MS-Like Syndrome

News

Researchers have developed a classification scheme for neuromyelitis optica spectrum disorder, a rare autoimmune disease that until recently was thought to be a type of multiple sclerosis (MS).

READ MORE

Epigenetic Regulator Identified as an Architect of Genome Folding

News

Researchers have shown the fundamental role of the heterochromatin protein 1a (HP1a) in the reorganization of the 3D chromatin structure after fertilization. By combining powerful Drosophila genetics with 3D genome modeling, they discovered that HP1a is required to establish a proper chromatin 3D structure at multiple hierarchical levels during early embryonic development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE